Exelixis vs. Intas: the quiet power struggle behind normal oncology progress
In the oncology world, the headline story is usually about better drugs, better outcomes, and faster approvals. But behind the scenes, another competition is often just as dec…
ð¨ The next big pharmaceutical IP fight isnt just about patentsits about what real exclusivity looks like in the age of generics.
Amneal Pharmaceuticals LLC v. Alembic Pharmaceuticals Ltd. (DrugPatentWatch coverage) spotlights a growing fault line …
Amneal Pharmaceuticals LLC v. Alembic Pharmaceuticals Ltd. Read Post »
ð¨ Patent litigation isnt just a legal eventits a capital markets event.
For investors tracking the oncology pipeline, the latest chapter in Exelixis (EXEL)s ongoing dispute with HANDA Pharmaceuticals is a reminder that the time value of drugs can …
Takeda v. Sun isnt just another patent headlineits a real-time stress test for how companies defend brand value, manage litigation risk, and decide whether to keep betting on long-tail IP in a tightening regulatory environment.
At its core, the case (T…
TAKEDA PHARMACEUTICALS U.S.A., INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD. Read Post »
A Next-Gen Drug Patent Fight Is Brewingand It Matters for Investors Who Care About Timing
Theres a special kind of risk in biopharmanot the business risk you can model in a quarterly forecast, but the legal/market risk that can quietly decide whether a…
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited Read Post »
Vertex Pharmaceuticals recent litigation posture in Vertex Pharmaceuticals, Inc. v. Squires is a reminder that innovation in pharma is only half the story. The other half is a high-stakes, timeline-driven contest over exclusivitywhere the calendar can …
Are you looking for Adefovir dipivoxil (brand Hepsera) and want info about a discount card (copay savings / patient savings… https://www.Drugchatter.com/chat/59984/adefovir-dipivoxil-discount-card/
Brand patents dont crumble because of vibes. They crumble because of patternsprocedural, evidentiary, and economicshowing up long before a final Board decision. The most underused asset in pharma litigation isnt a memo or a claim chart. Its PTAB data.
…
How to Use PTAB Data to Predict Which Brand Patents Will Crumble Read Post »
Short answer: Yesmost clinicians recommend checking liver‑function tests (LFTs) before starting simvastatin (Lipitor)… https://www.Drugchatter.com/chat/30440/is-liver-function-monitoring-necessary-with-lipitor/
DrugChatter: Is liver function monitoring necessary with lipitor? Read Post »
Short answer: there arent strict food bans with low-dose aspirin, but some things can raise bleeding… https://www.Drugchatter.com/chat/56866/foods-to-avoid-whilst-taking-low-dose-aspirin-hns/
DrugChatter: Foods to avoid whilst taking low dose aspirin hns? Read Post »
Get new actionable insights and updates from BiotechBlog
